Figure 4From: A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patientsKaplan-Meier and log-rank analysis for 72 neuroblastoma patients without MYCN amplification. OS (A) and EFS (B) of patients classified according to the NB-hypo. Solid and dashed curves represent good and poor prognosis patients, respectively. The p-value of the log-rank test is shown.Back to article page